Open AccessSerum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach
Author(s) -
Katsunori Iijima,
Yasuhiko Abe,
Ryosuke Kikuchi,
Tomoyuki Koike,
Shuichi Ohara,
P Sipponen,
Tooru Shimosegawa
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.853
Subject(s) - atrophic gastritis , gastroenterology , medicine , biomarker , gastritis , helicobacter pylori , stomach , gastric mucosa , antrum , biopsy , atrophy , rapid urease test , pathology , biology , biochemistry
To study the value of serum biomarker tests to differentiate between patients with healthy or diseased stomach mucosa: i.e. those with Helicobacter pylori (H pylori) gastritis or atrophic gastritis, who have a high risk of gastric cancer or peptic ulcer diseases.